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sPredictors of Stroke and Paraplegia in Thoracic Aortic Endovascular
Intervention
Clough R.E., Modarai B., Topple J.A., Bell R.E., Carrell T.W.G., Zayed
H.A., WalthamM., Taylor P.R. Eur J Vasc Endovasc Surg 2011;41:303-10.
Background: Endoluminal repair of thoracic aortic pathology has
become established in clinical practice, but is associated with significant
neurological complications. The aim of this study was to identify factors that
were predictive of stroke and paraplegia.
Methods: Prospective data was collected for a cohort of 293 consecu-
tive patients having thoracic aortic endovascular repair between August
1997 and September 2009. Patient and procedural characteristics were
related to the incidence of stroke and paraplegia using multivariate logistic
regression analysis.
Results: The median age was 68 years (18–87), there were 191 men
and 102 women. Mortality was 5.1% for 195 elective and 13.4% for 98
urgent patients. Stroke affected 16 (5.5%) patients: 11 affected the anterior
and 5 the posterior circulation. Coverage of the left subclavian artery with no
revascularisation was the only significant factor predictive of stroke (OR 5.34
(1.42–20.40) P  0.01). Paraplegia affected 16 patients (5.5%) but no
independent risk factor was identified: 12 were identified perioperatively and
4 were delayed by up to 6 months.
Conclusion: Covering the left subclavian artery without revascularisa-
tion increases the risk of stroke following endoluminal repair of thoracic
pathology. Paraplegia appears to be more complex and no independent
precipitating factor was identified.
Sizing Fenestrated Aortic Stent-grafts
Malkawi A.H., Resch T.A., Bown M.J., Manning B.J., Poloniecki J.D.,
Nordon I.M., Loftus I.M., Thompson M.M., Hinchliffe R.J. Eur J Vasc
Endovasc Surg 2011;41:311-6.
Introduction: Fenestrated aortic stent-grafts are increasingly being
used to treat patients with juxtarenal abdominal aortic aneurysms (AAA).
Sizing of these stent-grafts is critical to ensure success and requires detailed
expert assessment of aortic morphology. At present little is known about
how sizing of these stent-grafts varies between observers and the necessary
tolerances involved to ensure a successful procedure.
Methods: CT scans of 19 consecutive patients with juxtarenal aortic
aneurysms that underwent successful endovascular repair with fenestrated
stent-grafts were selected. Sizing of fenestrated aortic stent-grafts was per-
formed independently by four experienced endovascular surgeons and re-
sults were compared. Data from the stent-graft manufacturer was available
for comparison in 12 cases.
Results: All observers agreed on the number of fenestrations; 16
devices had 3 fenestrations and 3 had 4. The overall inter-observer measure-
ment error for all target vessel orientation was12.6° (10.8–14.4 95% CI),
and for distance between target vessels 5.3 mm (4.4–6.2 95% CI). The
median difference in internal stent-graft diameter was 1 stent size. Agree-
ment on fenestration type ranged from (84–95%). Comparison was per-
formed with the manufactured stent-graft in 12 cases. The overall mean
difference of target vessel orientation between the manufactured devices and
the four observers was1.3° (SD  6.9,3.8–1.2 95% CI). There was less
agreement between observers and device manufacturers on body and limb
lengths and distal limb diameters.
Conclusions: There was generally a high level of agreement between
experienced endovascular surgeons in sizing the fenestrated stent compo-
nent. There were differences in component lengths but these could have
been accommodated by varying the degree of overlap between components.
Early and Long-term Outcome after Thoracic Endovascular Aortic
Repair (TEVAR) for Acute Complicated Type B Aortic Dissection
Steuer J., Eriksson M.-O., Nyman R., Björck M., Wanhainen A. Eur J Vasc
Endovasc Surg 2011;41:318-23.
Objectives: The study aimed to investigate early and long-term out-
come of thoracic endovascular aortic repair (TEVAR) for acute complicated
type B dissection.
Design: This was a retrospective, single-centre, consecutive case series.
Materials andMethods:During the period 1999–2009, TEVAR wascarried out in 50 patients with non-traumatic acute complicated type B
dissection, and in another 10 patients with acute complications, including
t
iupture, end-organ ischaemia and acute dilatation during the primary hos-
italisation, but 14 days after onset of symptoms. Thus, in total, 60
atients were included; 22 with a DeBakey type IIIa dissection and 38 with
type IIIb; median age was 67 years. Early (30-day) and long-term (5-year)
urvival, re-intervention rate and complications were recorded until 1 July
010.
Results: Within 30 days, two (3%) deaths, one (2%) paraplegia and
hree (5%) strokes were observed. Five-year survival was 87% and freedom
rom re-intervention at 5 years was 65%.
Conclusions: In patients with acute complicated type B aortic dissec-
ion, TEVAR can be performed with excellent early and long-term survival,
hereas morbidity and long-term durability must be further elucidated.
uality of Life in Patients with Small Abdominal Aortic Aneurysm:
he Effect of Early Endovascular Repair Versus Surveillance in the
AESAR Trial
e Rango P., Verzini F., Parlani G., Cieri E., Romano L., Loschi D., Cao P.,
or the Comparison of surveillance vs. Aortic Endografting for Small Aneu-
ysm Repair (CAESAR) Investigators. Eur J Vasc Endovasc Surg 2011;41:
24-31.
Objective: To evaluate and compare changes over time in health-
elated quality of life reported by patients with small (4.1–5.4 cm) abdom-
nal aortic aneurysms (AAAs) undergoing endovascular aortic aneurysm
epair (EVAR) or surveillance.
Methods: Participants were randomly assigned to receive either early
VAR or surveillance within a multicentre, randomised clinical trial on small
AA (Comparison of surveillance vs. Aortic Endografting for Small Aneu-
ysm Repair, CAESAR). Patient-reported health-related quality of life was
ssessed before randomisation, at 6 months and yearly thereafter using the
hort Form 36 (SF-36) Health Survey.
Results: Between 2004 and 2008, 360 patients (345 males, mean age
8.9 years) were randomised, 182 to early EVAR and 178 to surveillance.
here was one perioperative death. Mean follow-up was 31.8 months. No
ignificant difference in survival was found. At baseline, comparable quality
f life scores were recorded in both treatment groups: Total SF-36: 73.0
ersus 75.5 (p  0.18), Physical domain: 71.4 versus 73.3 (p  0.33);
ental health domain: 70.9 versus 72.7 (p  0.33), in the EVAR arm versus
he surveillance arm, respectively. Six months after randomisation, Total
F-36 and Physical and Mental domain scores were all significantly higher
ith respect to baseline in the EVAR group, while patients of the surveil-
ance group scored lower. The differences between EVAR and surveillance
rms in score changes at 6 months were significant and in favour of EVAR:
otal score: difference 5.4; p  0.0017; Physical: difference 3.8; p  0.02;
nd Mental: difference 6.0; p  0.0005. Differences between EVAR and
urveillance diminished over time. At the last assessment, patients in both
roups had decreased scores with a significant drop with respect to the
aseline (3.9 in EVAR, 6.3 in surveillance). There were no significant
ifferences between the EVAR and surveillance arms: Total score: p  0.25;
hysical: p  0.47; and Mental: p  0.38.
Conclusions: Patients with small AAA under surveillance compared
ith early EVAR had significant impaired functional health at 6 months after
ssignment. After amean of 31.8months, SF-36 health-related quality of life
n patients allocated to early EVAR and surveillance was similar.
rgent Carotid Endarterectomy in Patients with Recent/Crescendo
ransient Ischaemic Attacks or Acute Stroke
origo W., Pulli R., Nesi M., Alessi Innocenti A., Pratesi G., Inzitari D.,
ratesi C. Eur J Vasc Endovasc Surg 2011;41:351-7.
Objectives: Objective of this study was to review the results of urgent
arotid endarterectomy (CEA) performed in patients with recent (24 h) or
rescendo (at least 2 episodes in 24 h) transient ischaemic attack (TIA) or
ith acute stroke in a single centre experience.
Materials and Methods: From January 2000 to December 2008, 75
atients underwent urgent CEA for severe internal carotid artery stenosis
nd recent/crescendo TIA (51 patients, TIA group) or acute stroke (24
atients, stroke group). In patients with acute stroke the intervention was
roposed on the basis of clinical and instrumental features (patient con-
cious, patency of middle cerebral artery, no lesions or limited brain infarc-
ion at CT scan) according to neurologists’ suggestion. Data from all the
nterventions were prospectively collected in a dedicated database, which
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March 2011882 Abstractsincluded main pre-, intra- and postoperative parameters. Independent neu-
rological assessment with National Institute of Health Stroke Scale (NIHSS)
score calculation was performed before the operation and within the 30th
postoperative day.
Early (30 days) results were evaluated in terms of mortality, modifi-
cations in NIHSS values and stroke and death rates. The surveillance
program consisted of clinical and ultrasonographic examinations at 1, 6 and
12 months and yearly thereafter. Follow-up results (survival, occurrence of
ipsilateral stroke in TIA group, recurrence of stroke in stroke group) were
analysed by Kaplan–Meier curves.
Results: Among patients presenting with TIA, 28 had crescendo TIAs
and 23 had a recent TIA; In stroke group, two patients had a stroke in
evolution, eight patients had a recent major non-disabling stroke and 14
patients had a recent minor stroke.
Preoperativemean value ofNIHSS score in stroke groupwas 4.7 (SD3.2).
There were 2 perioperative (30 days) deaths, both in stroke group, in
one case due to acute respiratory failure and to fatal stroke in the other one
(preoperative NIHSS value 9, postoperative 17), with a cumulative 30-day
mortality rate of 2.7%, significantly higher in stroke group (8.3%) than in TIA
group (no death, p 0.03). No postoperative cerebral haemorrhage occurred.
In TIA group one postoperative major stroke occurred, with a 30-day
stroke and death rate of 1.9%.
In surviving patients of stroke group NIHSS value improved in 13
cases, with a mean improvement of 2 points (SD 0.9); in 8 cases the value
remained unchanged, while in the remaining case it increased from 2 to 4.
Mean postoperative NIHSS score in stroke group was 3.9 (SD 3.7), signif-
icantly reduced in comparison with preoperative value (p  0.001).
Mean duration of follow-up was 34 months (SD 28.1). No ipsilateral
stroke in patients of TIA group occurred; in stroke group a recurrent fatal
stroke at 1 postoperative month was recorded. Estimated 48-month stroke-
free survival rate TIA group was 95% and 79% in stroke group (p  0.02).
Conclusions: Urgent CEA in patients with recent/crescendo TIA
provided in our experience excellent results, with low rates of perioperative
and late stroke. In selected patients with acute stroke early surgery seems to
provide acceptable results.
Patients’ Radiation Doses During the Implantation of Stents in Ca-
rotid, Renal, Iliac, Femoral and Popliteal Arteries
Majewska N., Blaszak M.A., Juszkat R., Frankiewicz M., Makalowski M.,
Majewski W. Eur J Vasc Endovasc Surg 2011;41:372-7.
Objectives and Design: The aim of the study was to document the
radiation doses to patients during the implantation of stents in various arteries
and to discuss potential reasons for prolongation of radiological procedures.
Materials and Methods: Measurements of air kerma (Gy) and dose–
area product (Gy cm2) (DAP) were carried out simultaneously on a sample
of 345 patients, who underwent different interventional radiological proce-
dures involving angioplasty with stenting of 73 carotid (21.5%), 22 renal
(6.5%), 160 iliac (45%), 63 femoral (18.6%) and 27 popliteal (7.9%) arteries.
Results: The highest mean air kerma values for fluoroscopy and
exposure were found for renal angioplasty (340 and 420 mGy, respectively).
With regard to total DAP values, the highest were obtained for renal
(148 Gy cm2) and iliac/The Inter-Society Consensus for Management of
Peripheral Arterial Disease (TASC) II C (199 Gy cm2) stent implantation.
The lowest values were for carotid (53 Gy cm2), iliac/TASC II A
(6.3 Gy cm2) and femoral/TASC II A (53 Gy cm2) arteries. For 3.5% of the
patients, the air kerma was between 1 and 1.5 Gy and for 1.5%, it was
between 1.5 and 2 Gy.
Conclusions: In procedures performed on the arteries of the lower limbs,
a significantly higher dosewas received by patientswithTASC IIC lesions.With
regard to the number of stents implanted, the total DAP value was 50% higher
for simultaneous three-stent implantation than for one or two stents.
A Systematic Review of Free Tissue Transfer in the Management of
Non-traumatic Lower Extremity Wounds in Patients with Diabetes
Fitzgerald O’Connor E.J., Vesely M., Holt P.J., Jones K.G., Thompson
M.M., Hinchliffe R.J. Eur J Vasc Endovasc Surg 2011;41:391-9.
Objectives: Wounds of the lower limb in patients with diabetes are
frequently difficult to heal. Some wounds fail to heal despite optimal medical
and surgical care. This review examines the evidence for whether free tissue
transfer techniquesmay reduce the requirement of amputation in these patients.
Design: A systematic review.
Materials & Methods: Pubmed, Embase, AMED, SCOPUS and
CINAHL and Cochrane Library were searched for all articles on free tissue
transfer in lower limb wounds in patients with diabetes (September 2010).
Current experience, indications and outcomes were analysed.Readers can access EJVES articles at http://intl.eurgery. 63% of flaps were muscle based, 35% fasciocutaneous and 1.7%
mental. Pooled in-hospital mortality rate was 4.4%, flap survival was 92%
nd limb salvage rate of 83.4% over a 28 months average follow-up time.
Conclusions: In conclusion free tissue transfer achieves successful
ound healing in selected patients with diabetes and difficult to heal wounds
hat would have required amputation. Pre-operative optimisation of vascular
upply and eradication of infection is key to success. Objective wound
ssessment scores and a clear multidisciplinary team (MDT) approach would
mprove patient care.
oes Puncture Site Affect the Rate of Nerve Injuries Following En-
ovenous Laser Ablation of the Small Saphenous Veins?
oganci S., Yildirim V., Demirkilic U. Eur J Vasc Endovasc Surg 2011;41:
00-5.
Objectives: The small saphenous vein (SSV) lies in close relationship
ith sural nerve and is at risk of damage during surgery or vein ablation
rocedures on this vein. The aim of this study was to compare the effect of
uncture site for SSV endovenous laser ablation (EVLA) on the rate of
ost-operative sural nerve injury.
Design: Randomised controlled study.
Patients andMethods: Sixty patients with isolated SSV varicose veins (68
imbs) were randomised into two groups. All patients were treated with en-
ovenous laser ablation procedures using radial fibres and a 1470 nm diode
aser. InGroup 1, SSVswere canulated from lateralmalleolar part of the SSV. In
roup 2, SSVs were canulated in the mid-calf. EVLA procedures were per-
ormed by using 12 Wenergy and 70 J cm1 LEED (linear endovenous energy
ensity). Local pain, ecchymosis, induration and paraesthesia in treated regions,
ein diameter, treated vein length, tumescent anaesthesia volume, delivered
nergywere recorded. Follow-up visitswere arrangedon the 2ndpost-operative
ay, 7th day, 1st, 2nd, 3rd and 6th months.
Results: The mean SSV diameters at sapheno-popliteal junction (SPJ)
nd calf levels were Group 1 SPJ: 6.6 S.D. 1.2 mm, Calf: 5.1 S.D. 1.1 mm,
nd Group 2 SPJ: 6.8 S.D. 1.6 mm, Calf: 4.9 S.D. 1.3 mm. Adverse events
fter treatment were 1 patient with induration, 3 with ecchymosis and 6
inimal paraesthesia in Group 1 (malleolar) and 1 local pain, 4 minimal
cchymosis or induration and 1 paraesthesia in Group 2 (mid-calf). InGroup
in two patients the paraesthesia lasted 2 months and then resolved
pontaneously. In the remaining four patients’ paraesthesia resolved in less
han 1 month without treatment. In Group 2 paraesthesia resolved sponta-
eously in two weeks. Induration, ecchymosis and local pain also resolved in
ess than 2 weeks in both groups. There was no recanalisation or reflux in the
reated SSV of either group during the follow-up period.
Conclusion: Treatment of the SSV by endovenous laser ablation using
1470 nm laser and a radial fibre is safe and effective. Puncturing the vein at
id-calf level causes less post-operative nerve injury without affecting the
ecanalisation rates.
-cell-pre-stimulatedMonocytes Promote Neovascularisation in aMu-
ine Hind Limb Ischaemia Model
ellingman A.A., Zwaginga J.J., van Beem R.T., TeRM/Smart Mix Con-
ortium, Hamming J.F., Fibbe W.E., Quax P.H.A., Geutskens S.B. Eur J
asc Endovasc Surg 2011;41:418-28.
Aim:Monocytes play a significant role in neovascularisation. The stimuli
hat differentiate monocytes along a pro-angio-/arteriogenic-supporting path-
ay are currently unclear. We investigated whether pre-stimulation of human
onocytes with soluble T-cell-derived factors improves revascularisation in
urine hind limb ischaemia as a new option for therapeutic angio- and arterio-
enesis.
Design: Human monocytes were cultured with or without soluble
-cell-derived factors. Unstimulated and pre-stimulated monocytes were
ransfused after induction of hind limb ischaemia in nude mice.
Methods: Blood flow was measured with laser Doppler perfusion
maging. Collaterals were visualised by immunohistochemistry and angiog-
aphy. Monocytes were characterised by flowcytometry and Bio-Plex assays.
Results: Transfusion of T-cell-pre-stimulated monocytes significantly
mproved blood flow recovery after hind limb ischaemia and increased
ollateral size and collateral and capillary number in the post-ischaemic paw.
re-stimulated monocytes produced a wide variety of factors that support
eovascularisation such as platelet-derived growth factor-BB, vascular-en-
othelial growth factor, interleukin-4 and tumour necrosis factor-. Few
ransfused human cells were detected in the muscle tissue, suggesting that
aracrine rather than direct effects appear responsible for the enhanced
ecovery of blood flow observed.
Conclusion:These results show a beneficial role for T-cell-pre-stimulated
onocytes in neovascularisation, rendering the monocyte a potential candidateResults: 528 patients from 18 studies were included in the systematic
review. 66% of patients had concomitant revascularisation with bypass
for regenerative cell therapy that promotes revascularisation in peripheral arterial
disease patients.lsevierhealth.com/journals/ejvs/default.cfm
